• Publisher Correction: Ketamine reduces the neural distinction between self- and other-produced affective touch: a randomized double-blind placebo-controlled study
  Published on 2024-07-22
  2 years ago
• Environmental and neurodevelopmental contributors to youth mental illness
  Published on 2024-07-19
  2 years ago
• Neuroimaging education in psychiatric training
  Published on 2024-07-18
  2 years ago
• Transcranial photobiomodulation: an emerging therapeutic method to enhance brain bioenergetics
  Published on 2024-07-18
  2 years ago
• Biomarker development for menstrual cycle affective change: the need for greater temporal, mechanistic, and phenotypic specificity
  Published on 2024-07-18
  2 years ago
• Is treatment-resistant schizophrenia a neuroimmune condition? Meta-analytic evidence from magnetic resonance spectroscopy
  Published on 2024-07-18
  2 years ago
• Acute, chronic and conditioned effects of intranasal oxytocin in the mu-opioid receptor knockout mouse model of autism: Social context matters
  Published on 2024-07-17
  2 years ago

« Previous 1 … 90 91 92 93 94 … 143 Next »

• A phase 1 study to assess potential interaction between ASP8062 and alcohol in healthy adult subjects
  Published on 2022-01-07
  5 years ago
• Incident infection during the first year of treatment – A comparison of clozapine and paliperidone palmitate long-acting injection
  Published on 2022-01-07
  5 years ago
• Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes
  Published on 2022-01-05
  5 years ago
• Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience
  Published on 2022-01-05
  5 years ago
• MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults
  Published on 2022-01-05
  5 years ago
• The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation
  Published on 2022-01-04
  5 years ago
• Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia
  Published on 2022-01-04
  5 years ago

« Previous 1 … 90 91 92 93 94 … 154 Next »

• Pharmacological characterization of 3,4-methylenedioxamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA
  Published on 2022-04-02
  4 years ago
• Is it time to change the term negative symptoms?
  Published on 2022-04-02
  4 years ago
• Psychiatric disorders in Post-acute COVID-syndrome (PDPACS): Recommendations for health care professionals
  Published on 2022-03-27
  4 years ago
• Corrigendum to “34th ECNP Congress – Lisbon 2021 Hybrid. P.0877 Lithium treatment influences blood transcriptome during manic but not depressive episode in bipolar patients” [European Neuropsychopharmacology 2021 53S1. S642]
  Published on 2022-03-23
  4 years ago
• Psychotherapeutic interventions specifically developed for NSSI in adolescence: A systematic review
  Published on 2022-03-22
  4 years ago
• Pediatric Bipolar Disorder – Misinformation with Unintended Negative Consequences for Children and Adolescents
  Published on 2022-03-21
  4 years ago
• Early intervention comes late
  Published on 2022-03-20
  4 years ago

« Previous 1 … 90 91 92 93 94 … 170 Next »